Literature DB >> 1372673

Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.

A J Lategan1, M R Marien, F C Colpaert.   

Abstract

Pretreatment of rats with the noradrenergic neurotoxin DSP-4 selectively reduced regional levels of noradrenaline in the brain by more than 75%, and decreased the concentration of endogenous DA in microdialysates of the caudate nucleus and nucleus accumbens by 52% and 28%, respectively. Results support the hypothesis that central noradrenergic mechanisms facilitate nigrostriatal and mesolimbic dopamine transmission in vivo.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1372673     DOI： 10.1016/0024-3205(92)90093-5

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


  23 in total

1.  Influence of noradrenaline denervation on MPTP-induced deficits in mice.

Authors:  T Archer; A Fredriksson
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

2.  Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.

Authors:  J Srinivasan; W J Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2004-12-22       Impact factor: 3.575

3.  Effect of locus coeruleus denervation on levodopa-induced motor fluctuations in hemiparkinsonian rats.

Authors:  C Marin; E Aguilar; M Bonastre
Journal:  J Neural Transm (Vienna)       Date:  2008-06-05       Impact factor: 3.575

4.  Postnatal iron overload destroys NA-DA functional interactions.

Authors:  A Fredriksson; T Archer
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

5.  Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.

Authors:  Ariana Q Farrand; Kristi L Helke; Rebecca A Gregory; Monika Gooz; Vanessa K Hinson; Heather A Boger
Journal:  Brain Stimul       Date:  2017-08-24       Impact factor: 8.955

Review 6.  Noradrenergic Modulation on Dopaminergic Neurons.

Authors:  Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2018-03-23       Impact factor: 3.911

7.  The catecholaminergic neurotransmitter system in methylmercury-induced neurotoxicity.

Authors:  Marcelo Farina; Michael Aschner; João Batista Teixeira da Rocha
Journal:  Adv Neurotoxicol       Date:  2017-09-01

8.  Presynaptic alpha 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices.

Authors:  A U Trendelenburg; K Starke; N Limberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

9.  The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?

Authors:  J Srinivasan; Werner J Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-29       Impact factor: 3.000

10.  The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.

Authors:  Antti Haapalinna; Tiina Leino; Esa Heinonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.